Cord Blood Stem Cells - A Global Market Overview (Related Reports)

Cord Blood Stem Cells - A Global Market Overview


October 13, 2011
282 Pages - SKU: IDXP6620709
License type:
Online Download      US $4,050.00
Global Site License      US $5,850.00
Cancer Stem Cells Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
Cancer Stem Cells Drug Pipeline Update 2014 Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and  |  read more...
$5,622.50
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts Summary Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in  |  read more...
$4,450.00
MediPoint: Bone Grafts and Substitutes - APAC Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
MediPoint: Bone Grafts and Substitutes - APAC Analysis and Market Forecasts Summary Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a  |  read more...
$4,450.00
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr
2/4/2014 | published by: MarketsandMarkets
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO)  |  read more...
$4,650.00
Complete 2013-14 Induce Pluripotent Stem Cell Industy Report
2/1/2014 | published by: BioInformant Worldwide, L.L.C.
Complete 2013-14 Induce Pluripotent Stem Cell Industy Report EXECUTIVE SUMMARY Stem cell research and experimentation has been in process for well over five decades, as stem  |  read more...
$3,495.00
Circulating Tumor Cells and Cancer Stem Cells Technologies
3/1/2014 | published by: Global Industry Analysts
Circulating Tumor Cells and Cancer Stem Cells Technologies This report analyzes the worldwide markets for Circulating Tumor Cells and Cancer Stem Cells Technologies in US$ Million. The report provides separate comprehensive analytics for  |  read more...
$4,950.00
MediPoint: Bone Grafts and Substitutes - EU Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
MediPoint: Bone Grafts and Substitutes - EU Analysis and Market Forecasts Summary Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a  |  read more...
$4,450.00
Cell Therapy Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
Cell Therapy Deals and Alliances of 2013 The Cell Therapy Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies  |  read more...
$1,495.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
8/15/2013 | published by: Kalorama Information
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the  |  read more...
$3,995.00
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
5/23/2013 | published by: Kalorama Information
The global blood industry has experienced strong growth in recent years and although this brisk expansion will slow somewhat as products continue to mature and pricing pressures increase, growth will remain solid though  |  read more...
$3,500.00